Company: INTS
Filing Date: 2025-06-12
Form Type: 424B5
Source: 0001628280-25-031040
Chunk: 29

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-06-12
Form: 424B5
Chunk 29
---
 right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.

The underwriter proposes to offer the shares of common stock offered by us to the public at the public offering price set forth on the cover of this prospectus supplement. In addition, the underwriter may offer some of the shares of common stock to other securities dealers at such price less a concession of $0.012 per share.

We have granted the underwriter an over-allotment option. This option, which is exercisable for up to 45 days after the date of this prospectus supplement, permits the underwriter to purchase a maximum of additional shares of common stock from us to cover over-allotments, if any. If the underwriter exercises all or part of this option, it will purchase shares of common stock covered by the option at the public offering price that appears on the cover page of this prospectus supplement, less the underwriting discount. If this option is exercised in full, the total price to the public will be approximately $2.3 million and the total proceeds to us, before expenses, will be approximately $2.1 million.

Discounts and Commissions. The following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriter of its over-allotment option.

|                                  |     | Per Share |       |     | Total                  
 Without Over-Allotment |           |     | With Over-Allotment |           |
|:---------------------------------|:----|:----------|------:|:----|:-----------------------|----------:|:----|:--------------------|----------:|
| Public offering price            |     | $         | 0.300 |     | $                      | 2,002,500 |     | $                   | 2,302,875 |
| Underwriting discount (7%)       |     | $         | 0.021 |     | $                      |   140,175 |     | $                   |   161,201 |
| Proceeds, before expenses, to us |     | $         | 0.279 |     | $                      | 1,862,325 |     | $                   | 2,141,674 |

In addition, we have agreed to pay a non-accountable expense allowance to the underwriter equal to 1% of the gross proceeds received in this offering (excluding proceeds received from exercise